Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API

Д.К. Махкамова

6 ta ish

Tashkent Institute of Postgraduate Medical Education, 51 Parkent St., Tashkent, Uzbekistan, 100009

  1. Etiopathogenesis of ocular ischemic syndrome

    Д.К. Махкамова

    Sharh maqolaCerebrovascular and Carotid Artery DiseasesRussian Annals of Ophthalmology20171 iqtibos
    ABI

  2. LEVEL OF MARKERS OF NEURODEGENERATION IN PATIENTS WITH OCULAR ISCHEMIC SYNDROME

    H. M. Kamilov, Munirahon Kasimova, Д.К. Махкамова

    MaqolaNeurological Disorders and TreatmentsEuropean Medical Health and Pharmaceutical Journal20140 iqtibos
    ABI

  3. EVALUATING THE EFFECTIVENESS OF FRUCTOSE-1,6-DIPHOSPHATE IN TREATING OF OCULAR ISCHEMIC SYNDROME

    Д.К. Махкамова

    MaqolaCerebrovascular and Carotid Artery DiseasesEuropean Medical Health and Pharmaceutical Journal20150 iqtibos
    ABI

  4. Analysis of choline alfoscerate effectiveness in chronic ocular ischemic syndrome

    Х. М. Камилов, М.С. Касимова, Д.К. Махкамова

    MaqolaNeurological Disorders and TreatmentsRussian Annals of Ophthalmology20160 iqtibos
    ABI

  5. Рenetrating operations of the eyeball as triggering factor of ocular ischemic syndrome

    Д.К. Махкамова

    MaqolaCerebrovascular and Carotid Artery DiseasesOphthalmology in Russia20160 iqtibos
    ABI

  6. Short-term efficacy of a monoclonal antibody fragment (brolucizumab) for treating neovascular age-related macular degeneration

    A.F. Yusupov, М.Х. Каримова, Sh.A. Djamalova +5

    MaqolaRetinal Diseases and TreatmentsOftalmologicheskii Zhurnal20240 iqtibos
    ABI